The Fund aims to provide long-term capital growth.
Name | % Net Assets |
---|---|
Roche Holding | 3.2% |
Reckitt Benckiser | 2.4% |
Fortum | 2.1% |
CVS Caremark Corp | 2.0% |
Keyence Corp | 1.9% |
Monsanto | 1.9% |
Computer Associates | 1.8% |
Lab Corp of America | 1.8% |
Waste Management | 1.8% |
FTI Consulting | 1.7% |
Key | % Net Assets |
---|---|
Roche Holding | 3.2% |
Reckitt Benckiser | 2.4% |
Fortum | 2.1% |
CVS Caremark Corp | 2.0% |
Other | 90.3% |
Date | 21-Nov-2024 |
---|---|
NAV | 381.70p |
Currency | GBP |
Change | 0.80p |
% | 0.21% |
YTD change | 56.10p |
YTD % | 17.23% |
Fund Inception | 09/09/1987 |
---|---|
Fund Manager | Sophie Horsfall |
TER | 2.33 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £1,000 |
Savings | £50 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.01 |
You are here: research